Volkan Korten

3.9k total citations
81 papers, 1.5k citations indexed

About

Volkan Korten is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Volkan Korten has authored 81 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 27 papers in Epidemiology and 21 papers in Molecular Medicine. Recurrent topics in Volkan Korten's work include Antibiotic Resistance in Bacteria (21 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antibiotic Use and Resistance (10 papers). Volkan Korten is often cited by papers focused on Antibiotic Resistance in Bacteria (21 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Antibiotic Use and Resistance (10 papers). Volkan Korten collaborates with scholars based in Türkiye, United States and United Kingdom. Volkan Korten's co-authors include Barbara E. Murray, Roland Leclercq, P Van der Auwera, Zekaver Odabaşı, W M Huang, Elif Tükenmez Tigen, İftihar Köksal, Serhat Ünal, Mehmet Sönmez and Ercüment Ovalı and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Volkan Korten

78 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Volkan Korten Türkiye 19 787 399 344 310 223 81 1.5k
Sang Taek Heo South Korea 25 951 1.2× 521 1.3× 496 1.4× 117 0.4× 312 1.4× 129 2.0k
Diamantis P. Kofteridis Greece 27 725 0.9× 1.0k 2.5× 732 2.1× 237 0.8× 215 1.0× 107 2.4k
Yong Pil Chong South Korea 28 1.5k 1.9× 1.0k 2.6× 459 1.3× 512 1.7× 432 1.9× 200 2.8k
Ayşe Erbay Türkiye 23 570 0.7× 479 1.2× 297 0.9× 98 0.3× 346 1.6× 87 1.6k
Steven Thijsen Netherlands 28 1.3k 1.7× 1.5k 3.7× 317 0.9× 224 0.7× 270 1.2× 94 2.8k
Yu Mi Wi South Korea 26 510 0.6× 588 1.5× 724 2.1× 264 0.9× 121 0.5× 98 1.7k
Imad Kassis Israel 23 648 0.8× 967 2.4× 287 0.8× 186 0.6× 481 2.2× 110 2.3k
İftihar Köksal Türkiye 25 1.3k 1.6× 820 2.1× 377 1.1× 147 0.5× 603 2.7× 139 2.5k
Esragül Akıncı Türkiye 24 839 1.1× 398 1.0× 269 0.8× 70 0.2× 472 2.1× 78 1.7k
Thøger Gorm Jensen Denmark 25 567 0.7× 798 2.0× 127 0.4× 340 1.1× 248 1.1× 91 2.1k

Countries citing papers authored by Volkan Korten

Since Specialization
Citations

This map shows the geographic impact of Volkan Korten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkan Korten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkan Korten more than expected).

Fields of papers citing papers by Volkan Korten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volkan Korten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkan Korten. The network helps show where Volkan Korten may publish in the future.

Co-authorship network of co-authors of Volkan Korten

This figure shows the co-authorship network connecting the top 25 collaborators of Volkan Korten. A scholar is included among the top collaborators of Volkan Korten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volkan Korten. Volkan Korten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yılmaz, İsmail, Ahmet Aksoy, Yasemin Özsürekçi, et al.. (2025). A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine. Vaccine. 49. 126787–126787. 2 indexed citations
2.
Okuyan, Betül, Buket Ertürk Şengel, Uluhan Sili, et al.. (2023). Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic. Turkish Journal of Pharmaceutical Sciences. 21(2). 152–158. 1 indexed citations
3.
Çağlayık, Dilek Yağcı, Elif Tükenmez Tigen, Uluhan Sili, et al.. (2023). Prevalence of Polypharmacy and Potential Drug–Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study. AIDS Patient Care and STDs. 37(3). 138–145. 4 indexed citations
4.
Bilgin, Hüseyin, Uluhan Sili, Eda Kepenekli, et al.. (2023). Effect of video camera monitoring feedback on hand hygiene compliance in neonatal intensive care unit, an interventional study. American Journal of Infection Control. 51(9). 1028–1033. 2 indexed citations
5.
Şengel, Buket Ertürk, et al.. (2022). Medication Reconciliation Service in Hospitalized Patients with Infectious Diseases During Coronavirus Disease-2019 Pandemic: An Observational Study. Turkish Journal of Pharmaceutical Sciences. 20(4). 210–217. 3 indexed citations
6.
Aydın, Mehtap, et al.. (2022). Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19. The Journal of Infection in Developing Countries. 16(3). 435–444. 4 indexed citations
7.
Şengel, Buket Ertürk, et al.. (2021). Evaluation of different respiratory samples and saliva for the detection of SARS-CoV-2 RNA. Marmara medical journal. 34(1). 51–56. 4 indexed citations
8.
Korten, Volkan, Deniz Gökengin, Taner Yıldırmak, et al.. (2021). Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017. AIDS Research and Therapy. 18(1). 4–4. 16 indexed citations
9.
Demirtaş, Coşkun Özer, Buket Ertürk Şengel, İsmail Cinel, et al.. (2021). Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study. International Journal of Clinical Practice. 75(9). e14363–e14363. 7 indexed citations
10.
Yağcı, Ayşegül, et al.. (2021). Comparison of SARS-COV-2 antibody assays in PCR negative and PCR positive Turkish patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2795–2797. 1 indexed citations
12.
Tigen, Elif Tükenmez, et al.. (2020). Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study. Expert Review of Hematology. 13(8). 923–927. 13 indexed citations
13.
Şengel, Buket Ertürk, et al.. (2020). In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and/or NDM-producing Klebsiella pneumoniae. Journal of Chemotherapy. 32(5). 237–243. 16 indexed citations
14.
Avkan-Oğuz, Vildan, et al.. (2020). Antimicrobial Resistance and Molecular Patterns in Community-acquired Complicated Intra-abdominal Infections: A Multicentric Study. Hitit University Institutional Repository. 2(2). 71–77. 2 indexed citations
15.
Sayan, Murat, Fatma Sargın, Dilara İnan, et al.. (2015). HIV-1 Transmitted Drug Resistance Mutations in Newly Diagnosed Antiretroviral-Naive Patients in Turkey. AIDS Research and Human Retroviruses. 32(1). 26–31. 13 indexed citations
16.
Korten, Volkan, Deniz Gökengin, Taner Yıldırmak, et al.. (2014). Outcomes of initial antiretroviral treatment (ART) among recently diagnosed HIV patients in HIV‐TR cohort, 2011–2012. Journal of the International AIDS Society. 17(4S3). 19678–19678. 11 indexed citations
17.
Eryüksel, Emel, et al.. (2009). Risk Factors for Mortality in Fungal Infections. Dspace Repository (Marmara Üniversitesi). 29(1). 99–103. 2 indexed citations
18.
Eraksoy, Haluk, Ahmet Başustaoğlu, Volkan Korten, et al.. (2007). Susceptibility of Bacterial Isolates From Turkey - A Report From the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program. Journal of Chemotherapy. 19(6). 650–657. 16 indexed citations
19.
Kaygusuz, Işık, et al.. (2003). An unusual native tricuspid valve endocarditis caused by Candida colliculosa. Clinical Microbiology and Infection. 9(4). 319–322. 10 indexed citations
20.
Moğulkoç, Nesrin, et al.. (1999). Acute Purulent Exacerbation of Chronic Obstructive Pulmonary Disease and Chlamydia pneumoniae Infection. American Journal of Respiratory and Critical Care Medicine. 160(1). 349–353. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026